Incidence and frequency of infections across trial and disease cohorts. (A) Percent of patients with and without infections by protocol between LD and D30. (B) Percent of patients with and without infections by disease type between LD and D30. (C) Percent of infections before and after D0 by protocol. (D) Percent of infections occurring before and after D0 by disease type.